Pacira BioSciences, Inc. (PCRX)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$22.99
-1.13%
Mkt Cap $904.31M
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (13 analysts)
$29.50
Range $27.00 – $32.00
Implied Upside
+28.3%
Consensus $29.50 vs current $22.99